当前位置:首页 > 通和毓承超募完成, 总资管规模逾百亿人民币_搜狐科技_搜狐网

通和毓承超募完成, 总资管规模逾百亿人民币_搜狐科技_搜狐网

时间:来源:B12

原标题:通和毓承超募完成, 总资管规模逾百亿人民币_搜狐科技_搜狐网

原标题:通和毓承超募完成, 总资管规模逾百亿人民币

2017年12月7日,上海, 波士顿, 香港, 旧金山。通和毓承今天宣布其合并后首支美元基金及首支人民币基金完成超额募集,基金规模分别达5.33亿美元及20.6亿人民币,超过原计划的4.5亿美元和15亿人民币。通和毓承由通和资本和毓承资本于2017年5月合并而来,对于中美两地市场均有深度覆盖和聚焦,已成为医疗健康领域内最大的投资机构之一。本次参与通和毓承美元基金认购的投资者包括业内知名的产业投资人、部分捐赠基金、另类资产管理机构以及主权财富基金等;参与通和毓承人民币基金认购的投资者包括业内知名的母基金、保险机构及产业投资人等。

谈及在短短六个月之内顺利完成新基金的募集,通和毓承创始合伙人兼首席执行官陈连勇博士表示:“通和毓承团队过往在创新投资模式、创造价值方面的能力得到大家的认可,对于业内资深投资者给予我们团队的信任和支持,我深感荣幸。我们建立了一支在跨太平洋两岸生命科学领域深度覆盖的专业投资团队,我们对于培育行业生态圈的初心不变,希望通过打造这个生态圈来进一步挖掘创新技术/产品、搭建平台型公司,以及帮助创业家们把他们的产业梦想转化为成功的商业实践。”

通和毓承创始合伙人兼董事长李革博士表示:“很高兴看到投资界和我们团队一样关注医疗健康领域的投资机会,我坚信新募集资金的注入能够更好地助力通和毓承夯实我们高度差异化的投资策略,并进一步强化我们在医疗健康投资领域内的领导地位。”

News | 6 Dimensions Capital Closed Oversubscribed 1st USD Fund and RMB Fund, Bringing Total AUM Over RMB 10Bn (USD 1.5Bn)

December 7, 2017, Shanghai, Boston, Hong Kong, San Francisco. 6 Dimensions Capital announces today the final close of its inaugural US dollar fund & RMB fund at US$533 million and RMB2.06 billion respectively, both exceeded the original US$450 million and RMB1.5 billion target. Formed through a merger between Frontline BioVentures and WuXi Healthcare Ventures in May 2017, 6 Dimensions Capital has established itself firmly as one of the largest healthcare focused investment firms with coverage across China and the U.S. Investors in the USD fund include some of the prominent industry leaders along with endowments, foundations, and sovereign wealth funds, and investors in the RMB fund include some of the top-tier fund-of-funds, mainstream insurance companies, and industrial leading players.

Commenting on the successful fund raising over a short six-month period, Dr. Leon Chen, Founding Partner & CEO of 6 Dimensions Capital, stated proudly, “I am grateful for the trust and support from many high-caliber investors, who recognize our proven abilities to create values through game changing investment practice. We have a capable professional team with cross-border coverage in the life sciences arena and we have the aspiration to foster the established ecosystem to identify innovations, build platform companies and help entrepreneurs transform their dreams to successful businesses.”

Dr. Ge Li, Founding Partner & Chairman of 6 Dimensions Capital, noted, “I am very pleased to see the enthusiasm from the investment community that embraces healthcare opportunities as much as we do. I believe this significant amount of fresh capital will empower the 6 Dimensions Capital team to execute our highly differentiated investment strategies and solidify our leadership in the healthcare venture investment.”返回搜狐,查看更多

责任编辑:

浙ICP备11025431号-1 声明:本网部分信息转载于其他网站,如稿件涉及版权等问题,请联系我们. 微信: inaniu!